Isidorianum : Impact Factor & More
eISSN: 2660-7743pISSN: 1131-7027
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Isidorianum Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Facultad de Teología San Isidoro de Sevilla |
| Language | English,French,German,Italian,Portuguese,Spanish |
| Publication Time | 12 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English,French,German,Italian,Portuguese,Spanish |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 12 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Isidorianum ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Isidorianum
Real-World Outcomes and Clinicopathologic Features of Human Epidermal Growth Factor Receptor 2-Low Breast Cancer in a Mexican Cohort.
- 1 Jun 2026
- JCO global oncology
Cessation of Betel Quid Chewing, Smoking, and Alcohol Drinking and Risk of Oral Precancer and Oral Cancer.
- 1 Jun 2026
- JCO global oncology
Treatment of ALK+ Non-Small Cell Lung Cancer in the Brazilian Public and Private Health Care Systems: A Tale of Inequalities (LACOG/GBOT 1918).
- 1 Jun 2026
- JCO global oncology
Evaluating the Impact of a Patient Navigation Program on Treatment Timeliness, Continuity, and Follow-Up Outcomes for Patients With Digestive Tract Cancer at Kenyatta Hospital.
- 1 Jun 2026
- JCO global oncology
Current Access to Anaplastic Lymphoma Kinase Testing and Targeted Therapies for Non-Small Cell Lung Cancer in Brazil: Results From a Cross-Sectional Survey (LACOG 1224-GBOT).
- 1 Jun 2026
- JCO global oncology
Targeting Inequities: Addressing Lung Cancer Care Challenges in Africa Through Drug Access, Radiotherapy, and Surgical Innovations.
- 1 Jun 2026
- JCO global oncology
Real-World Outcomes and Clinicopathologic Features of Human Epidermal Growth Factor Receptor 2-Low Breast Cancer in a Mexican Cohort.
- 1 Jun 2026
- JCO global oncology
Cessation of Betel Quid Chewing, Smoking, and Alcohol Drinking and Risk of Oral Precancer and Oral Cancer.
- 1 Jun 2026
- JCO global oncology
Treatment of ALK+ Non-Small Cell Lung Cancer in the Brazilian Public and Private Health Care Systems: A Tale of Inequalities (LACOG/GBOT 1918).
- 1 Jun 2026
- JCO global oncology
Evaluating the Impact of a Patient Navigation Program on Treatment Timeliness, Continuity, and Follow-Up Outcomes for Patients With Digestive Tract Cancer at Kenyatta Hospital.
- 1 Jun 2026
- JCO global oncology
Current Access to Anaplastic Lymphoma Kinase Testing and Targeted Therapies for Non-Small Cell Lung Cancer in Brazil: Results From a Cross-Sectional Survey (LACOG 1224-GBOT).
- 1 Jun 2026
- JCO global oncology
Targeting Inequities: Addressing Lung Cancer Care Challenges in Africa Through Drug Access, Radiotherapy, and Surgical Innovations.
- 1 Jun 2026
- JCO global oncology
FAQs on Isidorianum
How many articles did Isidorianum publish last year? 
What is the eISSN & pISSN for Isidorianum?
Who is the publisher of Isidorianum?
